Phnride MP 2mg/500mg/15mg Tablet
Marketer
Indophin Remedies Pvt. Ltd.
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Phnride MP 2mg/500mg/15mg Tablet
Metformin-pioglitazone-glipizide tablets (2mg/500mg/15mg) are a triple-combination medication designed to manage blood glucose. This therapy, used in conjunction with diet and exercise, improves glycemic control in adult patients with type 2 diabetes. It enhances insulin effectiveness, resulting in reduced blood sugar. Adhere strictly to your physician's prescribed dosage and regimen. Taking this medication with food minimizes gastrointestinal discomfort. If a dose is missed, take it immediately; however, if the next dose is imminent, omit the missed dose and resume your regular schedule. Never double the dose; overdose can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or meal skipping may increase the risk of hypoglycemia. Regular blood sugar monitoring is essential. Common adverse reactions include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals must consult their physician before use. Kidney function tests will be performed prior to treatment initiation. Limit alcohol consumption as it can amplify side effects.
Primary Ingredients of Phnride MP 2mg/500mg/15mg Tablet
No text was provided to rewrite. Please provide the text you would like me to rephrase.
Uses of Phnride MP 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Phnride MP 2mg/500mg/15mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Phnride MP 2mg/500mg/15mg Tablet whole; do not bite, pulverize, or fracture it. Administer this medication with a meal.
Common Side effects of Phnride MP 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Phnride MP 2mg/500mg/15mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Phnride MP 2mg/500mg/15mg Tablet whole; do not chew, crush, or divide it. Administer this medication with food.
How Phnride MP 2mg/500mg/15mg Tablet works:
Phnride MP tablets (2mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple combination enhances blood sugar management when single or dual drug therapies prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Phnride MP 2mg/500mg/15mg tablets is dangerous.
PregnancyCONSULT YOUR DOCTOR
The use of Phnride MP 2mg/500mg/15mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
The use of Phnride MP 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if such symptoms manifest.
KidneyCAUTION
Exercise caution when administering Phnride MP 2mg/500mg/15mg tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. The use of Phnride MP 2mg/500mg/15mg tablets is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended throughout the treatment period.
LiverCAUTION
Exercise caution when administering Phnride MP 2mg/500mg/15mg Tablets to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Phnride MP 2mg/500mg/15mg Tablets are contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Phnride MP 2mg/500mg/15mg Tablet :
Should you forget to take a Phnride MP 2mg/500mg/15mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Phnride MP 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently